Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:August 22, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:August 22, 2022Recruiting
Condition(s):Hyperphagia in Prader-Willi SyndromeLast Updated:March 5, 2024Recruiting
Condition(s):Hyperphagia; Prader-Willi SyndromeLast Updated:April 26, 2019Completed
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:October 7, 2021Completed
Condition(s):Prader-Willi Syndrome; HyperphagiaLast Updated:April 18, 2023Completed
Condition(s):HyperphagiaLast Updated:March 29, 2023Recruiting
Condition(s):HealthyLast Updated:March 21, 2022Completed
Condition(s):Hyperphagia in Prader-Willi SyndromeLast Updated:July 28, 2015Completed
Condition(s):ObesityLast Updated:March 29, 2021Completed
Condition(s):Angelman Syndrome; Smith-Magenis Syndrome; X Fragile Syndrome; Epilepsy; Prader-Willi SyndromeLast Updated:August 24, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.